ENDRA Life Sciences Inc (NDRA) - שולי רווח נקי

The commercial launch of liver diagnostic systems remains limited, which temporarily increases distribution costs for ENDRA Life Sciences (NDRA). However, the proprietary TAEUS method enables accurate screening for fatty liver disease via affordable ultrasound. The operating net margin confirms this trend, with the latest value recorded as 0.00. Ownership of unique software and sensors guarantees the company high scalability with low production costs.
פילוחי מדדים פיננסיים ומדדי שוק עבור ENDRA (NDRA)

ENDRA Life Sciences is developing the innovative liver ultrasound diagnostics sector through a system of patents and strategic alliances. The net_margin_co metric determines the share of net profit in total revenue, measuring the overall efficiency of the business. By analyzing the net profit margin on GURU.Markets, an investor can see the company's actual ability to convert revenue into profit. The dynamics of this indicator reveal the gap between operating expenses and the financial result. The stability of this curve serves as a signal for timely portfolio rebalancing.